These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 32038795)

  • 61. Tissue-specific alterations in the 6-hydroxylation of chlorzoxazone following traumatic brain injury in the rat.
    Poloyac SM; Perez A; Scheff S; Blouin RA
    Drug Metab Dispos; 2001 Mar; 29(3):296-8. PubMed ID: 11181498
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Antithrombotic effect of rutaecarpine, an alkaloid isolated from Evodia rutaecarpa, on platelet plug formation in in vivo experiments.
    Sheu JR; Hung WC; Wu CH; Lee YM; Yen MH
    Br J Haematol; 2000 Jul; 110(1):110-5. PubMed ID: 10930986
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Circadian rhythm of cytochrome P4502E1 and its effect on disposition kinetics of chlorzoxazone in rats.
    Khemawoot P; Nishino K; Ishizaki J; Yokogawa K; Miyamoto K
    Eur J Pharmacol; 2007 Nov; 574(1):71-6. PubMed ID: 17651723
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Multifaceted interaction of the traditional Chinese medicinal herb Schisandra chinensis with cytochrome P450-mediated drug metabolism in rats.
    Wang B; Yang S; Hu J; Li Y
    J Ethnopharmacol; 2014 Sep; 155(3):1473-82. PubMed ID: 25091466
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Rutaecarpine: A promising cardiovascular protective alkaloid from Evodia rutaecarpa (Wu Zhu Yu).
    Tian KM; Li JJ; Xu SW
    Pharmacol Res; 2019 Mar; 141():541-550. PubMed ID: 30616017
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Influence of diosmin pretreatment on the pharmacokinetics of chlorzoxazone in healthy male volunteers.
    Rajnarayana K; Venkatesham A; Nagulu M; Srinivas M; Krishna DR
    Drug Metabol Drug Interact; 2008; 23(3-4):311-21. PubMed ID: 19326774
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Elimination of rutaecarpine and its metabolites in rat feces and urine measured by liquid chromatography.
    Jan WC; Lin LC; Don MJ; Chen CF; Tsai TH
    Biomed Chromatogr; 2006 Nov; 20(11):1163-71. PubMed ID: 16799925
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Both cytochromes P450 2E1 and 1A1 are involved in the metabolism of chlorzoxazone.
    Carriere V; Goasduff T; Ratanasavanh D; Morel F; Gautier JC; Guillouzo A; Beaune P; Berthou F
    Chem Res Toxicol; 1993; 6(6):852-7. PubMed ID: 7509644
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Detection and characterization of the metabolites of rutaecarpine in rats based on ultra-high-performance liquid chromatography with linear ion trap-Orbitrap mass spectrometer.
    Cai W; Guan Y; Zhou Y; Wang Y; Ji H; Liu Z
    Pharm Biol; 2017 Dec; 55(1):294-298. PubMed ID: 27927077
    [TBL] [Abstract][Full Text] [Related]  

  • 70. In vivo and in vitro characterization of chlorzoxazone metabolism and hepatic CYP2E1 levels in African Green monkeys: induction by chronic nicotine treatment.
    Lee AM; Yue J; Tyndale RF
    Drug Metab Dispos; 2006 Sep; 34(9):1508-15. PubMed ID: 16763012
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Robustness of chlorzoxazone as an in vivo measure of cytochrome P450 2E1 activity.
    Ernstgård L; Warholm M; Johanson G
    Br J Clin Pharmacol; 2004 Aug; 58(2):190-200. PubMed ID: 15255802
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Functional characterization of human and cynomolgus monkey cytochrome P450 2E1 enzymes.
    Hanioka N; Yamamoto M; Iwabu H; Jinno H; Tanaka-Kagawa T; Naito S; Shimizu T; Masuda K; Katsu T; Narimatsu S
    Life Sci; 2007 Oct; 81(19-20):1436-45. PubMed ID: 17935737
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Cytochrome P-450 2E1 is not the sole catalyst of chlorzoxazone hydroxylation in rat liver microsomes. off.
    Jayyosi Z; Knoble D; Muc M; Erick J; Thomas PE; Kelley M
    J Pharmacol Exp Ther; 1995 Jun; 273(3):1156-61. PubMed ID: 7791086
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Chlormethiazole as an efficient inhibitor of cytochrome P450 2E1 expression in rat liver.
    Hu Y; Mishin V; Johansson I; von Bahr C; Cross A; Ronis MJ; Badger TM; Ingelman-Sundberg M
    J Pharmacol Exp Ther; 1994 Jun; 269(3):1286-91. PubMed ID: 8014872
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Characterization of cytochrome P450 2E1 induction in a rat hepatoma FGC-4 cell model by ethanol.
    McGehee RE; Ronis MJ; Cowherd RM; Ingelman-Sundberg M; Badger TM
    Biochem Pharmacol; 1994 Nov; 48(9):1823-33. PubMed ID: 7980652
    [TBL] [Abstract][Full Text] [Related]  

  • 76. The effect of quercetin on the pharmacokinetics of chlorzoxazone, a CYP2E1 substrate, in healthy subjects.
    Bedada SK; Neerati P
    Eur J Clin Pharmacol; 2018 Jan; 74(1):91-97. PubMed ID: 28983678
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Biotransformation of chlorzoxazone by hepatic microsomes from humans and ten other mammalian species.
    Court MH; Von Moltke LL; Shader RI; Greenblatt DJ
    Biopharm Drug Dispos; 1997 Apr; 18(3):213-26. PubMed ID: 9113344
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Therapeutic hypothermia-induced pharmacokinetic alterations on CYP2E1 chlorzoxazone-mediated metabolism in a cardiac arrest rat model.
    Tortorici MA; Kochanek PM; Bies RR; Poloyac SM
    Crit Care Med; 2006 Mar; 34(3):785-91. PubMed ID: 16521272
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Ultrasensitive quantification of the CYP2E1 probe chlorzoxazone and its main metabolite 6-hydroxychlorzoxazone in human plasma using ultra performance liquid chromatography coupled to tandem mass spectrometry after chlorzoxazone microdosing.
    Witt L; Suzuki Y; Hohmann N; Mikus G; Haefeli WE; Burhenne J
    J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Aug; 1027():207-13. PubMed ID: 27300008
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Inhibition of CYP2E1 by chlormethiazole as measured by chlorzoxazone pharmacokinetics in patients with alcoholism and in healthy volunteers.
    Eap CB; Schnyder C; Besson J; Savary L; Buclin T
    Clin Pharmacol Ther; 1998 Jul; 64(1):52-7. PubMed ID: 9695719
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.